Watchlist Price Alert

Lixte Biotechnology Inc. (LIXT)

NASDAQ: LIXT · Real-Time Price · USD

1.42

0.25 (21.37%)

At close: Jun 02, 2025, 3:59 PM

1.42

-0.29%

Pre-market: Jun 03, 2025, 08:31 AM EDT

Lixte Biotechnology Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-3.57M	-5.09M	-6.31M	-6.72M	-3.27M	-2.49M	-2.14M	-1.81M	-2.13M
Interest Income	7.05K	1.25K	11.2K	626.00	5.23K	49.72K	4.92K	1.38K	183.00
Pretax Income	-3.59M	-5.09M	-6.31M	-6.73M	-3.26M	-2.44M	-2.13M	-1.81M	-2.13M
Net Income	-3.59M	-5.09M	-6.3M	-6.74M	-3.26M	-2.39M	-2.13M	-1.81M	-2.13M
Selling & General & Admin	2.85M	4.19M	4.96M	4.98M	2.01M	1.67M	2.1M	1.34M	833.78K
Research & Development	726.23K	898.1K	1.35M	1.74M	1.22M	820.91K	40.7K	467.26K	1.3M
Other Expenses	n/a	n/a	n/a	n/a	33.81K	n/a	n/a	n/a	n/a
Operating Expenses	3.57M	5.09M	6.31M	6.72M	3.27M	2.49M	2.14M	1.81M	2.13M
Interest Expense	-16.82K	n/a	8.88K	7.41K	3.67K	n/a	4.92K	1.38K	183.00
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	3.57M	5.09M	6.31M	6.72M	3.27M	2.49M	2.14M	1.81M	2.13M
Income Tax Expense	n/a	n/a	-7.82K	6.79K	-1.56K	-49.72K	-9.85K	-1.81K	-2.13K
Shares Outstanding (Basic)	2.25M	1.91M	1.58M	1.35M	1.13M	1.12M	979.93K	930K	797K
Shares Outstanding (Diluted)	2.25M	1.92M	1.58M	1.35M	1.13M	1.12M	979.93K	930.29K	797.93K
EPS (Basic)	-1.59	-2.66	-4	-5	-2.89	-2.14	-2.18	-1.94	-2.68
EPS (Diluted)	-1.59	-2.66	-4	-5	-2.89	-2.14	-2.18	-1.94	-2.68
EBITDA	-3.57M	3.21K	-1.05K	-7.95K	1.56K	-2.49M	4.92K	1.38K	183.00
EBIT	-3.6M	-5.09M	-6.31M	-6.73M	-3.26M	-2.44M	-2.13M	-1.81M	-2.13M
Depreciation & Amortization	30K	5.09M	6.31M	6.72M	3.27M	2.49M	2.14M	1.81M	2.13M